Target's General Information
Target ID T13017
Target Name Syndecan-1 (SDC1)
Synonyms SYND1; SDC; CD138
Target Type Clinical trial
Gene Name SDC1
Biochemical Class Peptide translocating syndecan
Target's Expression Profile in Disease Related Tissue between Patients and Normal People
Disease Myeloma
Example drug Indatuximab Ravtansine? Phase 1/2 [1], [2], [3]
Tissue Bone marrow
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: 0.76
Z-score: 2.17
P-value: 1.62E-03
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target's Expression Profile across Various Tissues of Healthy Individual
REF 1 (NCT01001442) Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma. U.S. National Institutes of Health.
REF 2 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
REF 3 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.